share_log

綠葉製藥:自願性公告 - 注射用羅替戈汀緩釋微球(LY03003)治療帕金森病中國III期臨床試驗達到預設終點

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF ROTIGOTINE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY03003) IN PARKINSON''S DISEASE MET PRIMARY ENDPOINT IN CHINA

Jul 19, 2022 10:40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more